Literature DB >> 19635229

Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.

Larry K Kvols1, Kiran K Turaga, Jonathan Strosberg, Junsung Choi.   

Abstract

Management of liver metastasis from neuroendocrine tumors routinely includes an interventional radiologist. Hepatic artery embolization, either bland (transarterial embolization) or with chemotherapy (transarterial chemoembolization), has been shown to improve response rates in neuroendocrine metastases to the liver. Radiofrequency ablation, cryotherapy, and percutaneous alcohol ablation are important adjuncts or alternative treatments to surgical debulking. In this article, the authors examine important techniques in the armamentarium of the interventional radiologist.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635229     DOI: 10.6004/jnccn.2009.0053

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  8 in total

1.  A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors.

Authors:  J R Strosberg; J M Weber; J Choi; T L Campos; T L Valone; G Han; M J Schell; L K Kvols
Journal:  Ann Oncol       Date:  2012-02-08       Impact factor: 32.976

Review 2.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 3.  Treatment of liver metastases in patients with digestive neuroendocrine tumors.

Authors:  Roberta Elisa Rossi; Sara Massironi; Matilde Pia Spampatti; Dario Conte; Clorinda Ciafardini; Federica Cavalcoli; Maddalena Peracchi
Journal:  J Gastrointest Surg       Date:  2012-07-25       Impact factor: 3.452

4.  Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complication.

Authors:  James J Mezhir; Yuman Fong; Deborah Fleischer; Susan K Seo; Francesco D'Amico; Elena Petre; Anne M Covey; George I Getrajdman; Raymond H Thornton; Stephen B Solomon; William R Jarnagin; Karen T Brown
Journal:  J Vasc Interv Radiol       Date:  2010-12-31       Impact factor: 3.464

Review 5.  Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues.

Authors:  Parul Agarwal; Amr Mohamed
Journal:  Curr Treat Options Oncol       Date:  2022-08-08

Review 6.  Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

7.  Multimodal liver-directed management of neuroendocrine hepatic metastases.

Authors:  Mark A Lewis; Joleen Hubbard
Journal:  Int J Hepatol       Date:  2011-10-29

8.  Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Authors:  Yanji Luo; Jie Chen; Kun Huang; Yuan Lin; Minhu Chen; Ling Xu; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2017-02-23       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.